AIMD Ainos Inc.

Ainos Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Tsai Chun-Jung was granted 900,000 shares, increasing direct ownership by 170% to 1,427,900 units (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)
4/9/25 4:15:35 PM ET
$AIMD
Biotechnology: Pharmaceutical Preparations
Health Care
Director Lee Ting-Chuan was granted 900,000 shares, increasing direct ownership by 169% to 1,431,432 units (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)
4/9/25 4:15:38 PM ET
$AIMD
Biotechnology: Pharmaceutical Preparations
Health Care
CEO, PRESIDENT, CHAIRMAN Tsai Chun-Hsien was granted 900,000 shares, increasing direct ownership by 120% to 1,651,862 units (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)
4/9/25 4:15:36 PM ET
$AIMD
Biotechnology: Pharmaceutical Preparations
Health Care
Director Tsai Chun-Jung was granted 200,000 shares, increasing direct ownership by 61% to 527,900 units (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)
3/12/25 11:12:53 AM ET
$AIMD
Biotechnology: Pharmaceutical Preparations
Health Care
Director Wei Pao-Sheng was granted 150,000 shares, increasing direct ownership by 276% to 204,400 units (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)
3/12/25 11:12:48 AM ET
$AIMD
Biotechnology: Pharmaceutical Preparations
Health Care
Director Tsai Chung-Yi was granted 150,000 shares, increasing direct ownership by 276% to 204,400 units (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)
3/12/25 11:12:44 AM ET
$AIMD
Biotechnology: Pharmaceutical Preparations
Health Care
CFO Lee Hsin-Liang Christopher was granted 250,000 shares, increasing direct ownership by 948% to 276,376 units (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)
3/12/25 11:12:50 AM ET
$AIMD
Biotechnology: Pharmaceutical Preparations
Health Care
Director Lee Ting-Chuan was granted 200,000 shares, increasing direct ownership by 60% to 531,432 units (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)
3/12/25 11:12:46 AM ET
$AIMD
Biotechnology: Pharmaceutical Preparations
Health Care
CEO, PRESIDENT, CHAIRMAN Tsai Chun-Hsien was granted 200,000 shares, increasing direct ownership by 36% to 751,862 units (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)
3/12/25 11:12:45 AM ET
$AIMD
Biotechnology: Pharmaceutical Preparations
Health Care
Director Chang Wen-Han was granted 150,000 shares, increasing direct ownership by 139% to 257,733 units (SEC Form 4)
4 - Ainos, Inc. (0001014763) (Issuer)
3/12/25 11:12:51 AM ET
$AIMD
Biotechnology: Pharmaceutical Preparations
Health Care

Ainos Inc.

Recent Analyst Ratings for Ainos Inc.

Ainos Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Tsai Chun-Jung was granted 900,000 shares, increasing direct ownership by 170% to 1,427,900 units (SEC Form 4)

Director Lee Ting-Chuan was granted 900,000 shares, increasing direct ownership by 169% to 1,431,432 units (SEC Form 4)

CEO, PRESIDENT, CHAIRMAN Tsai Chun-Hsien was granted 900,000 shares, increasing direct ownership by 120% to 1,651,862 units (SEC Form 4)

Director Tsai Chun-Jung was granted 200,000 shares, increasing direct ownership by 61% to 527,900 units (SEC Form 4)

Director Wei Pao-Sheng was granted 150,000 shares, increasing direct ownership by 276% to 204,400 units (SEC Form 4)

Director Tsai Chung-Yi was granted 150,000 shares, increasing direct ownership by 276% to 204,400 units (SEC Form 4)

CFO Lee Hsin-Liang Christopher was granted 250,000 shares, increasing direct ownership by 948% to 276,376 units (SEC Form 4)

Director Lee Ting-Chuan was granted 200,000 shares, increasing direct ownership by 60% to 531,432 units (SEC Form 4)

CEO, PRESIDENT, CHAIRMAN Tsai Chun-Hsien was granted 200,000 shares, increasing direct ownership by 36% to 751,862 units (SEC Form 4)

Director Chang Wen-Han was granted 150,000 shares, increasing direct ownership by 139% to 257,733 units (SEC Form 4)